REVOLUTION MEDICINES INC
RVMDNASDAQ🏆 #336 by market capEarnings Nov 3 · PostUS Equity
$202.86▲ $1.14 (+0.56%)
LiveTrack RVMD
Get earnings, price moves & breaking news on Telegram
24h▲ 0.6%
7d▲ 5.1%
14d▼ 1.0%
30d▼ 2.4%
ytd▲ 154.7%
1y▲ 340.3%
🏦Market Cap
$43.13B
Mid Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
28
Weak
REVOLUTION MEDICINES INC
RVMDAnalyst Ratings
Price
$202.86
Total
24
Raised
0
Lowered
0
Avg PT
$252.35
H / L
$320 / $179
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
B of A Securities | Reiterated | Buy | 2026-09-21 | — | — |
Stifel | Reiterated | Buy | 2026-09-09 | — | — |
Needham | Reiterated | Buy | 2026-08-31 | $275.00 | +35.60% |
Guggenheim | Reiterated | Buy | 2026-08-28 | $275.00 | +35.60% |
UBS | Reiterated | Buy | 2026-08-28 | $265.00 | +30.60% |
Oppenheimer | Reiterated | Outperform | 2026-08-27 | $260.00 | +28.20% |
RBC Capital | Reiterated | Outperform | 2026-08-27 | $251.00 | +23.70% |
HC Wainwright & Co. | Reiterated | Buy | 2026-08-27 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2026-08-27 | — | — |
Truist Securities | Reiterated | Buy | 2026-08-27 | — | — |
Wedbush | Reiterated | Outperform | 2026-08-27 | $201.00 | −0.90% |
Bernstein | Reiterated | Market Perform | 2026-08-21 | $179.00 | −11.80% |
Mizuho | Reiterated | Outperform | 2026-07-06 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-05-07 | $75.00 | −63.00% |
Leerink Partners | Reiterated | Outperform | 2026-04-22 | — | — |
Wells Fargo | Reiterated | Overweight | 2026-04-14 | $144.00 | −29.00% |
JP Morgan | Reiterated | Overweight | 2026-02-02 | — | — |
Raymond James | Reiterated | Strong Buy | 2025-10-17 | $248.00 | +22.30% |
Goldman Sachs | Reiterated | Buy | 2025-09-12 | $267.00 | +31.60% |
Barclays | Reiterated | Overweight | 2024-09-27 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2024-03-08 | $255.00 | +25.70% |
SVB Leerink | Reiterated | Outperform | 2022-08-10 | — | — |
Cowen & Co. | Reiterated | Outperform | 2020-03-09 | — | — |
Guggenheim Securities | Reiterated | Buy | 2020-03-09 | — | — |
Institution
B of A Securities
Reiterated · Buy · 2026-09-21
—
—
Stifel
Reiterated · Buy · 2026-09-09
—
—
Needham
Reiterated · Buy · 2026-08-31
$275.00
+35.60%
Guggenheim
Reiterated · Buy · 2026-08-28
$275.00
+35.60%
UBS
Reiterated · Buy · 2026-08-28
$265.00
+30.60%
Oppenheimer
Reiterated · Outperform · 2026-08-27
$260.00
+28.20%
RBC Capital
Reiterated · Outperform · 2026-08-27
$251.00
+23.70%
HC Wainwright & Co.
Reiterated · Buy · 2026-08-27
—
—
Evercore ISI Group
Reiterated · Outperform · 2026-08-27
—
—
Truist Securities
Reiterated · Buy · 2026-08-27
—
—
Wedbush
Reiterated · Outperform · 2026-08-27
$201.00
−0.90%
Bernstein
Reiterated · Market Perform · 2026-08-21
$179.00
−11.80%
Mizuho
Reiterated · Outperform · 2026-07-06
—
—
Piper Sandler
Reiterated · Overweight · 2026-05-07
$75.00
−63.00%
Leerink Partners
Reiterated · Outperform · 2026-04-22
—
—
Wells Fargo
Reiterated · Overweight · 2026-04-14
$144.00
−29.00%
JP Morgan
Reiterated · Overweight · 2026-02-02
—
—
Raymond James
Reiterated · Strong Buy · 2025-10-17
$248.00
+22.30%
Goldman Sachs
Reiterated · Buy · 2025-09-12
$267.00
+31.60%
Barclays
Reiterated · Overweight · 2024-09-27
—
—
Morgan Stanley
Reiterated · Equal Weight · 2024-03-08
$255.00
+25.70%
SVB Leerink
Reiterated · Outperform · 2022-08-10
—
—
Cowen & Co.
Reiterated · Outperform · 2020-03-09
—
—
Guggenheim Securities
Reiterated · Buy · 2020-03-09
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space